According to the latest report by IMARC Group, titled “Deep Brain Stimulation Market Report by Stimulation Type (Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS, Pedunculopontine Nucleus DBS), Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator), Application (Parkinson's Disease (PD), Epilepsy, Dystonia, Obsessive Compulsive Disorder (OCD), and Others), End-User (Hospitals, Ambulatory Surgical Centers, Neurological Centers, and Others), and Region 2025-2033”, the global deep brain stimulation market size reached USD 1.4 Billion in 2024. Deep brain stimulation (DBS) refers to a neurosurgical procedure, which involves implanting a medical device called a neurostimulator that sends continuous electrical impulses to specific areas of the brain. The electrodes regulate abnormal impulses and evoke control over the neural activity within the region. It is considered a safe and effective method for treating numerous health conditions, including epilepsy, dystonia, essential tremor, Parkinson’s disease (PD) and obsessive-compulsive disorder (OCD). Apart from this, it is also utilized in the treatment of dementia, addiction, chronic pain, multiple sclerosis, depression, stroke recovery and traumatic brain injury.
Global Deep Brain Stimulation Market Trends:
Rising incidences of motor and neurological disorders, along with a lack of permanent treatment for neurological conditions such as PD, is one of the primary factors driving the market growth. A rise in the prevalence of stress and depression across the globe is another major growth-inducing factor. Furthermore, enhanced research and development (R&D) activities in the medical sector to develop innovative technologies are also providing a stimulus to the market growth. For instance, the advent of neurostimulators capable of delivering bilateral stimulation with a single device is creating a positive outlook for the market. Other factors contributing to the market growth include increasing geriatric population and rising awareness among the masses regarding the benefits of such procedures. Looking forward, the market value is projected to reach USD 2.8 Billion by 2033, expanding at a CAGR of 7.91% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Stimulation Types Covered | Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS, Pedunculopontine Nucleus DBS |
Products Covered | Single Channel, Dual Channel |
Applications Covered | Parkinson's Disease (PD), Epilepsy, Dystonia, Obsessive Compulsive Disorder (OCD), Others |
End-Users Covered | Hospitals, Ambulatory Surgical Centers, Neurological Centers, Others |
Region Covered | Asia Pacific, North America, Europe, Middle East and Africa, Latin America |
Companies Covered | Boston Scientific, Medtronic, St. Jude Medical, Aleva Neurotherapeutics, Beijing Pins Medical, NeuroPace and Neuro Sigma |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 | https://www.imarcgroup.com